PG
PGX icon

Prostatis Group’s Invesco Preferred ETF PGX Stock Holding History

Prostatis Group’s Portfolio PGX Stock Details PGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Hold
10,972
– – 0.03% 190
2026
Q1 		$119K Hold
10,972
– – 0.03% 167
2025
Q4 		$123K Hold
10,972
– – 0.03% 165
2025
Q3 		$127K Sell
10,972
-198
-2% -$2.27K 0.03% 165
2025
Q2 		$124K Buy
11,170
+2
+0% +$22 0.04% 156
2025
Q1 		$125K Buy
11,168
+1
+0% +$12 0.04% 151
2024
Q4 		$129K Buy
11,167
+110
+1% +$1.32K 0.04% 154
2024
Q3 		$137K Buy
11,057
+1
+0% +$12 0.04% 129
2024
Q2 		$128K Buy
11,056
+2
+0% +$23 0.04% 145
2024
Q1 		$131K Buy
11,054
+1
+0% +$12 0.05% 134
2023
Q4 		$127K Sell
11,053
-165
-1% -$1.8K 0.05% 129
2023
Q3 		$123K Buy
11,218
+167
+2% +$1.87K 0.06% 111
2023
Q2 		$126K Sell
11,051
-1,379
-11% -$15.6K 0.06% 128
2023
Q1 		$138K Sell
12,430
-550
-4% -$6.6K 0.07% 97
2022
Q4 		$145K Buy
12,980
+1,382
+12% +$16K 0.09% 96
2022
Q3 		$138K Buy
11,598
+10
+0.1% +$126 0.16% 63
2022
Q2 		$143K Buy
11,588
+9
+0.1% +$113 0.22% 46
2022
Q1 		$157K Buy
+11,579
New +$161K 0.13% 83

Other funds holding PGX

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.31B AUM 1.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Centiva Capital New York $11.5B AUM 31.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
SAMC
Spectrum Asset Management (Connecticut) Stamford, Connecticut $69.6M AUM 1.92% 1-Year Est. Return

Prostatis Group's PGX Position: Q2 2026 in Review

Prostatis Group held its Invesco Preferred ETF (PGX) position steady in Q2 2026 at 10,972 shares worth $119K. The position accounts for 0.03% of the portfolio, ranked #190.

Prostatis Group first reported a position in PGX in Q1 2022 and has held it in 18 quarters since. The position peaked at $157K in Q1 2022. 407 funds tracked by Wall St. Rank hold PGX as of Q2 2026.

  • Prostatis Group held 10,972 shares of Invesco Preferred ETF worth $119K as of Q2 2026.
  • Prostatis Group left its Invesco Preferred ETF share count unchanged in Q2 2026.
  • Invesco Preferred ETF made up 0.03% of Prostatis Group's portfolio in Q2 2026, its #190 holding.
  • Prostatis Group first reported a position in Invesco Preferred ETF in Q1 2022 and has held it in 18 quarters since.
  • Prostatis Group's Invesco Preferred ETF position peaked at $157K in Q1 2022.
  • 407 funds tracked by Wall St. Rank held Invesco Preferred ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.